[go: up one dir, main page]

IL136731A0 - Method for reducing susceptibility to hiv infection - Google Patents

Method for reducing susceptibility to hiv infection

Info

Publication number
IL136731A0
IL136731A0 IL13673198A IL13673198A IL136731A0 IL 136731 A0 IL136731 A0 IL 136731A0 IL 13673198 A IL13673198 A IL 13673198A IL 13673198 A IL13673198 A IL 13673198A IL 136731 A0 IL136731 A0 IL 136731A0
Authority
IL
Israel
Prior art keywords
hiv infection
reducing susceptibility
susceptibility
reducing
hiv
Prior art date
Application number
IL13673198A
Other languages
English (en)
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of IL136731A0 publication Critical patent/IL136731A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2086—IL-13 to IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13673198A 1997-12-19 1998-12-18 Method for reducing susceptibility to hiv infection IL136731A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6835597P 1997-12-19 1997-12-19
US9847498P 1998-08-31 1998-08-31
PCT/US1998/027005 WO1999032138A1 (fr) 1997-12-19 1998-12-18 Procede pour reduire la sensibilite a l'infection a vih

Publications (1)

Publication Number Publication Date
IL136731A0 true IL136731A0 (en) 2001-06-14

Family

ID=26748884

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13673198A IL136731A0 (en) 1997-12-19 1998-12-18 Method for reducing susceptibility to hiv infection

Country Status (6)

Country Link
EP (1) EP1059932A1 (fr)
JP (1) JP2001526241A (fr)
AU (1) AU2004199A (fr)
CA (1) CA2313805A1 (fr)
IL (1) IL136731A0 (fr)
WO (1) WO1999032138A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
AU2002232447A1 (en) * 2000-11-02 2002-05-15 Immunex Corporation Method of enhancing lymphocyte-mediated immune responses
US7175988B2 (en) 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
US7175838B2 (en) 2001-08-23 2007-02-13 The United States Of America Represented By The Department Of Health And Human Services Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state
US7393934B2 (en) 2001-12-21 2008-07-01 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
NZ570709A (en) * 2003-06-13 2010-04-30 Univ Pennsylvania Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
JP2008507255A (ja) 2004-03-12 2008-03-13 ヒューマン　ジノーム　サイエンシーズ，　インコーポレイテッド ヒトｇタンパク質ケモカインレセプター（ｃｃｒ５）ｈｄｇｎｒ１０
EP1768662A2 (fr) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
AU2006202318A1 (en) 2005-06-02 2006-12-21 Wing-Yee Chan The preparation of multipotent stem cells and the use thereof
EP2066339B1 (fr) 2006-09-18 2014-08-13 The Board Of Trustees Of The University Of Arkansas Compositions et procédés pour améliorer des réponses immunes
NZ585776A (en) 2007-10-30 2012-07-27 Univ Arkansas Compositions and methods of enhancing immune responses to flagellated bacterium
WO2009059298A2 (fr) 2007-11-01 2009-05-07 Board Of Trustees Of The University Of Arkansas Compositions et procédés pour amplifier des réponses immunitaires à l'eimeria
CN102811734B (zh) 2010-01-21 2016-02-10 阿肯色大学评议会 增强免疫应答的疫苗载体和方法
ES2753142T3 (es) 2010-06-09 2020-04-07 Univ Arkansas Vacuna y métodos para reducir una infección por Campylobacter
ES2968398T3 (es) 2013-02-14 2024-05-09 Univ Arkansas Composiciones y métodos para potenciar las respuestas inmunitarias a Eimeria o limitar la infección por Eimeria
EP3578190A1 (fr) 2013-03-15 2019-12-11 The Board of Trustees of the University of Arkansas Compositions et procédés pour améliorer les réactions immunitaires aux pathogènes entériques
TWI843057B (zh) 2016-05-03 2024-05-21 阿肯色州大學董事會 包含免疫刺激性及抗原性多肽的酵母菌疫苗載體以及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1059095A (en) * 1993-11-24 1995-06-13 Australian National University, The Treatment of viral disease with cd40l peptide
CA2179196A1 (fr) * 1993-12-23 1995-06-29 Richard J. Armitage Procede de prevention ou de traitement de maladies caracterisees par des cellules neoplasiques exprimant le cd40
DK0812206T3 (da) * 1995-03-01 2002-09-09 Immunex Corp Fremgangsmåde til stimulering af en immunrespons

Also Published As

Publication number Publication date
JP2001526241A (ja) 2001-12-18
WO1999032138A1 (fr) 1999-07-01
CA2313805A1 (fr) 1999-07-01
EP1059932A1 (fr) 2000-12-20
AU2004199A (en) 1999-07-12

Similar Documents

Publication Publication Date Title
HK1024237A1 (en) PROCESS TO PREPARE ε-CAPROLACTAM
IL136731A0 (en) Method for reducing susceptibility to hiv infection
GB9500327D0 (en) alpha - pyrimidinyl acrylic acid derivatives
ID22098A (id) Metode menghilangkan coret-coretan
EP1050583A4 (fr) Inhibiteurs d'infections a vih
GB9407886D0 (en) Purification process
ZA958282B (en) Purification process
GB2323745B (en) System and method relating to telecommunications
GB9518997D0 (en) Improvements relating to trolleys
GB9909749D0 (en) Purification method
GB2301079B (en) Improvements relating to gripper sleeves
ZA983900B (en) Process to 5-methyleneoxazolenes
EP0708336A3 (fr) Méthode de distinguer les progéniteurs granulomonocytiques
GB9805572D0 (en) Improvements relating to support slings
GB9426105D0 (en) Improvements relating to electrolevels
GB9608251D0 (en) Improvements in or relating to gripping devices
GB9700375D0 (en) Purification process
ZA981983B (en) Purification process
GB9612759D0 (en) Improvements relating to pendants
HUP9801978A3 (en) Process for purifying phosphoryl-chloride
GB9708544D0 (en) Improvements relating to lifting devices
GB9424701D0 (en) Improvements relating to ear-rings
IL159737A (en) Process to produce oxazolidinones
GB9402134D0 (en) Improvements relating to jewellery articles
AUPP098797A0 (en) Methods for treating hepatitis infection